| Name | Alamar Biosciences, Inc. |
|---|---|
| CIK | 0002104204 |
| Tickers | ALMR |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 3826 Laboratory Analytical Instruments |
| EIN | 364899036 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 510-626-9888 |
| Website | — |
| Investor website | — |
| Owner org | 08 Industrial Applications and Services |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
66 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-19 | 4/A | xslF345X06/form4a-11192026_091152.xml | 0002126944-26-000009 | 17716 | ||||||
| 2026-11-19 | 3/A | xslF345X06/form3a-11192026_091128.xml | 0002126944-26-000007 | 6166 | ||||||
| 2026-11-13 | 4 | xslF345X06/form4-11142026_021118.xml | 0001231919-26-001575 | 31333 | ||||||
| 2026-11-05 | 4 | xslF345X06/form4-11052026_041101.xml | 0001231919-26-001540 | 24833 | ||||||
| 2026-11-04 | 10-Q | 10-Q | 0001193125-26-445905 | 001-43235 | 261519734 | 34 | 15742544 | 1 | 1 | |
| 2026-11-03 | 4 | xslF345X06/form4-11032026_041117.xml | 0001231919-26-001531 | 56878 | ||||||
| 2026-11-03 | 8-K | 8-K | 2.02,5.02,9.01 | 0001193125-26-445353 | 001-43235 | 261517474 | 34 | 674982 | 1 | 1 |
| 2026-10-29 | 4 | xslF345X06/form4-10292026_081054.xml | 0001231919-26-001508 | 50780 | ||||||
| 2026-10-27 | 4 | xslF345X06/form4-10272026_041002.xml | 0001231919-26-001501 | 50775 | ||||||
| 2026-10-23 | 4 | xslF345X06/form4-10232026_111021.xml | 0001231919-26-001497 | 57255 | ||||||
| 2026-10-21 | 4 | xslF345X06/form4-10212026_071001.xml | 0001231919-26-001485 | 44294 | ||||||
| 2026-10-19 | 4 | xslF345X06/form4-10192026_081007.xml | 0001231919-26-001469 | 37059 | ||||||
| 2026-10-14 | 144 | xsl144X01/primary_doc.xml | 0001231919-26-001458 | 001-43235 | 261461110 | 33 | 5240 | |||
| 2026-10-14 | 144 | xsl144X01/primary_doc.xml | 0001231919-26-001456 | 001-43235 | 261461100 | 33 | 4732 | |||
| 2026-10-14 | 144 | xsl144X01/primary_doc.xml | 0001231919-26-001455 | 001-43235 | 261461094 | 33 | 5808 | |||
| 2026-10-14 | 144 | xsl144X01/primary_doc.xml | 0001231919-26-001454 | 001-43235 | 261461087 | 33 | 5748 | |||
| 2026-09-16 | 4 | xslF345X06/form4-09162026_080954.xml | 0001823381-26-000014 | 7484 | ||||||
| 2026-09-16 | 3 | xslF345X06/form3-09162026_080932.xml | 0001823381-26-000012 | 8319 | ||||||
| 2026-09-03 | 4 | xslF345X06/form4-09032026_080949.xml | 0001222644-26-000004 | 7419 | ||||||
| 2026-09-03 | 3 | xslF345X06/form3-09032026_080909.xml | 0001222644-26-000002 | 8376 | ||||||
| 2026-09-01 | 8-K | 8-K | 5.02 | 0001193125-26-378360 | 001-43235 | 261350610 | 34 | 137686 | 1 | 1 |
| 2026-08-13 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002126941-26-000007 | 005-95626 | 261274797 | 34 | 7378 | |||
| 2026-08-11 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002059127-26-000005 | 005-95626 | 261263912 | 34 | 27417 | |||
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-343003 | 001-43235 | 261260308 | 34 | 12517692 | 1 | 1 | |
| 2026-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-342378 | 001-43235 | 261258483 | 34 | 640001 | 1 | 1 |
| 2026-07-15 | 8-K | 8-K | 8.01 | 0001193125-26-304736 | 001-43235 | 261177417 | 34 | 136835 | 1 | 1 |
| 2026-07-07 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001875620-26-000010 | 005-95626 | 261159926 | 34 | 16886 | |||
| 2026-07-02 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001862953-26-000003 | 005-95626 | 261147890 | 34 | 156641 | |||
| 2026-05-08 | 10-Q | 10-Q | 0001193125-26-213424 | 001-43235 | 26956197 | 34 | 9896449 | 1 | 1 | |
| 2026-05-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-213379 | 001-43235 | 26956141 | 34 | 471219 | 1 | 1 |
| 2026-04-23 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-173780 | 005-95626 | 26888995 | 34 | 125865 | |||
| 2026-04-23 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001875620-26-000007 | 005-95626 | 26887376 | 34 | 45113 | |||
| 2026-04-22 | 4 | xslF345X06/form4-04222026_080434.xml | 0001231919-26-000392 | 55043 | ||||||
| 2026-04-20 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001252 | 333-294697 | 26876622 | 33 | 1753 | ||
| 2026-04-20 | 4 | 4 | 0001193125-26-164634 | 37048 | ||||||
| 2026-04-20 | 4 | xslF345X06/form4-04212026_120444.xml | 0001823563-26-000013 | 8039 | ||||||
| 2026-04-20 | 4 | xslF345X06/form4-04212026_120458.xml | 0001455312-26-000004 | 16912 | ||||||
| 2026-04-20 | 4 | xslF345X06/form4-04212026_120426.xml | 0002126704-26-000004 | 41983 | ||||||
| 2026-04-20 | 4 | xslF345X06/form4-04212026_120439.xml | 0002126944-26-000004 | 29739 | ||||||
| 2026-04-20 | 4 | xslF345X06/form4-04212026_120453.xml | 0002126941-26-000004 | 63115 | ||||||
| 2026-04-20 | 4 | xslF345X06/form4-04212026_120457.xml | 0001786386-26-000006 | 12162 | ||||||
| 2026-04-20 | 4 | xslF345X06/form4-04212026_120442.xml | 0001534166-26-000006 | 34119 | ||||||
| 2026-04-20 | S-8 | S-8 | 0001193125-26-164128 | 333-295193 | 26875555 | 33 | 245791 | 1 | 1 | |
| 2026-04-20 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-26-163921 | 001-43235 | 26875014 | 34 | 184433 | 1 | 1 |
| 2026-04-20 | POS AM | POS AM | 0001193125-26-162823 | 333-294697 | 26873455 | 33 | 44305 | |||
| 2026-04-17 | 424B4 | 424B4 | 0001193125-26-161647 | 333-294697 | 26872078 | 33 | 8373704 | |||
| 2026-04-16 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001218 | 333-294697 | 26869299 | 33 | 1740 | ||
| 2026-04-16 | 3 | 3 | 0001193125-26-159904 | 19838 | ||||||
| 2026-04-16 | 3 | xslF345X06/form3-04172026_010412.xml | 0001231919-26-000375 | 28225 | ||||||
| 2026-04-16 | 3 | xslF345X06/form3-04172026_010403.xml | 0001455312-26-000002 | 12341 | ||||||
| 2026-04-16 | 3 | xslF345X06/form3-04172026_010434.xml | 0001304782-26-000002 | 8459 | ||||||
| 2026-04-16 | 3 | xslF345X06/form3-04172026_010412.xml | 0001823563-26-000011 | 9868 | ||||||
| 2026-04-16 | 3 | xslF345X06/form3-04172026_010429.xml | 0001534166-26-000004 | 18109 | ||||||
| 2026-04-16 | 3 | xslF345X06/form3-04172026_010401.xml | 0001786386-26-000004 | 9849 | ||||||
| 2026-04-16 | 3 | xslF345X06/form3-04172026_010442.xml | 0002126704-26-000002 | 18197 | ||||||
| 2026-04-16 | 3 | xslF345X06/form3-04172026_010457.xml | 0002126944-26-000002 | 15922 | ||||||
| 2026-04-16 | 3 | xslF345X06/form3-04172026_010416.xml | 0002126941-26-000002 | 24488 | ||||||
| 2026-04-16 | S-1MEF | S-1MEF | 0001193125-26-159789 | 333-295116 | 26869084 | 33 | 189506 | 1 | 1 | |
| 2026-04-16 | CERT | ALMR_8A_Cert_2104204.pdf | 0001354457-26-000353 | 001-43235 | 26867080 | 34 | 178897 | |||
| 2026-04-16 | S-1/A | S-1/A | 0001193125-26-158122 | 333-294697 | 26865929 | 33 | 8451848 | |||
| 2026-04-15 | 8-A12B | 8-A12B | 0001193125-26-156986 | 001-43235 | 26864159 | 34 | 13675 | |||
| 2026-04-13 | S-1/A | S-1/A | 0001193125-26-151891 | 333-294697 | 26856355 | 33 | 14416185 | 1 | 1 | |
| 2026-03-27 | S-1 | S-1 | 0001193125-26-129039 | 333-294697 | 26807469 | 33 | 13489783 | 1 | 1 | |
| 2026-03-12 | DRS/A | filename1.htm | 0001193125-26-104470 | 377-08929 | 26749137 | 33 | 6481393 | |||
| 2026-02-17 | DRS/A | filename1.htm | 0001193125-26-054940 | 377-08929 | 26642918 | 33 | 3580499 | |||
| 2026-01-09 | DRS | filename1.htm | 0001193125-26-009127 | 377-08929 | 26524072 | 33 | 4049237 |
One latest value per concept from companyfacts (169 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 69.48M | 2026-10-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 22,561.31 | 2026-04-20 | S-8 | 2026-04-20 | 0001193125-26-164128 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 22,561.31 | 2026-04-20 | S-8 | 2026-04-20 | 0001193125-26-164128 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 163.37M | 2026-04-20 | S-8 | 2026-04-20 | 0001193125-26-164128 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-04-20 | S-8 | 2026-04-20 | 0001193125-26-164128 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-04-16 | S-1MEF | 2026-04-16 | 0001193125-26-159789 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 16.55M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 21.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 561,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 14.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 7.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -173,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 520.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 3.83M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 800,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-08 | 0001193125-26-213424 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 8.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 100,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | AllowanceForDoubtfulAccountsReceivableWriteOffs | Accounts Receivable, Allowance for Credit Loss, Writeoff | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-08 | 0001193125-26-213424 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 203,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 9.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | Assets | Assets | USD | 378.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 317.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | CapitalizedComputerSoftwareNet | Capitalized Computer Software, Net | USD | 1.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 121.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 126.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 126.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 91.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 31,251 | 2026-04-19 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 1.00B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 7,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -47.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 457,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 1.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 363,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 235.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ConvertibleDebt | Convertible Debt | USD | 56.50M | 2026-01-08 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ConvertibleDebtFairValueDisclosures | Convertible Debt, Fair Value Disclosures | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | CostOfRevenue | Cost of Revenue | USD | 36.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 66.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | DebtConversionConvertedInstrumentSharesIssued1 | Debt Conversion, Converted Instrument, Shares Issued | shares | 3.91M | 2026-04-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 2.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 3.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.02 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.02 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 12,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 53.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 117,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ForeignCurrencyTransactionGainLossUnrealized | Foreign Currency Transaction Gain (Loss), Unrealized | USD | -303,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | GrossProfit | Gross Profit | USD | 52.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -47.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 465,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 9.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 9.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncreaseDecreaseInContractWithCustomerAsset | Increase (Decrease) in Contract with Customer, Asset | USD | -69,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 17.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -1.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | -1.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 447,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 2.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | InterestExpenseOperating | InterestExpenseOperating | USD | 600,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | InterestIncomeOperating | Interest Income, Operating | USD | 4.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 563,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 16.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | InventoryNet | Inventory, Net | USD | 54.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 31.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 6.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.104 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 79.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 6.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 9.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 8.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 7.41M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 29.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | Liabilities | Liabilities | USD | 74.32M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 378.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 33.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 0 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 247.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -109.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -46.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -47.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 93.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -41.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 42.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 2.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 39.87M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 1.30M | 2026-04-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343003 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 36.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 4.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 2.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -171,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | 70,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | -34,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 974,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | -395,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 443,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 6.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 4.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 124.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | PaymentsToDevelopSoftware | Payments to Develop Software | USD | 466,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 20.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 15.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 56.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 197.80M | 2026-04-20 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 204.54M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 10.00M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments | Proceeds from Sale, Maturity and Collection of Short-term Investments | USD | 20.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ProductWarrantyAccrualClassifiedCurrent | Product Warranty Accrual, Current | USD | 995,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 15.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | PropertyPlantAndEquipmentTransfersAndChanges | Property, Plant and Equipment, Transfers and Changes | USD | 2.17M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 118,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | RepaymentsOfLinesOfCredit | Repayments of Lines of Credit | USD | 10.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 43.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 4.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -216.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 89.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 89.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 11.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 50.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 8.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 8,945 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343003 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 7.59 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-11 | 0001193125-26-343003 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 18,955 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 4.18 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 15,922 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.68 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 104.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 3.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 3.23 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 4.50M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-08 | 0001193125-26-213424 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 86,064 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 8.54 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 3.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 4.89 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-08 | 0001193125-26-213424 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 216.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 8.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 8.07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 216.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 8.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 8.07 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2.86 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 14.1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 17 | 2026-04-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 105.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | StandardProductWarrantyAccrualPayments | Standard Product Warranty Accrual, Decrease for Payments | USD | 1.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | StandardProductWarrantyAccrualWarrantiesIssued | Standard Product Warranty Accrual, Increase for Warranties Issued | USD | 1.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 103,000 | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 303.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 303.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 12.94M | 2026-04-20 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 1.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 235.00M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 197.84M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 270,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 235.00M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 46.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 46.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-445905 |